Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2928 |
|
| Actual shortage: | 212 (7%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2706 (92%) | |
Discontinuation Reports |
299 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 297 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
361 (11%) |
|
Overdue reports |
85 (40%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-AMPHETAMINE XR | 20MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-08-18 | 2022-10-29 | 167226 |
| TEVA-AMPHETAMINE XR | 10MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2022-10-17 | 2023-07-28 | 172027 |
| TEVA-AMPICILLIN | 500MG | CAPSULE | Resolved | 2022-10-28 | 2022-11-12 | 173034 |
| TEVA-AMPICILLIN | 500MG | CAPSULE | Resolved | 2023-10-19 | 2023-11-09 | 207494 |
| TEVA-AMPICILLIN | 250MG | CAPSULE | Resolved | 2020-05-14 | 2020-09-03 | 115210 |
| TEVA-AMPICILLIN | 500MG | CAPSULE | Resolved | 2020-05-14 | 2020-06-25 | 115213 |
| TEVA-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2020-05-01 | 2020-05-14 | 113800 |
| TEVA-ARIPIPRAZOLE | 30MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86825 |
| TEVA-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86945 |
| TEVA-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86948 |
| TEVA-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86951 |
| TEVA-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86954 |
| TEVA-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86957 |
| TEVA-ARIPIPRAZOLE | 30MG | TABLET | Resolved | 2019-06-27 | 2019-10-10 | 87687 |
| TEVA-ATAZANAVIR | 200MG | CAPSULE | Resolved | 2020-04-10 | 2020-04-23 | 111810 |
| TEVA-ATAZANAVIR | 300MG | CAPSULE | Resolved | 2020-04-10 | 2020-07-23 | 111813 |
| TEVA-ATAZANAVIR | 200MG | CAPSULE | Resolved | 2017-08-21 | 2017-09-19 | 19928 |
| TEVA-ATAZANAVIR | 200MG | CAPSULE | Resolved | 2021-01-15 | 2021-01-21 | 131688 |
| TEVA-ATENOLOL | 100MG | TABLET | Resolved | 2020-07-30 | 2020-09-03 | 121515 |
| TEVA-ATENOLOL | 25MG | TABLET | Actual shortage | 2020-01-24 | 2020-01-24 | 104310 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-ATORVASTATIN | 20MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64612 |
| TEVA-AZITHROMYCIN | 250MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255821 |
| TEVA-CARBAMAZEPINE | 200MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14052 |
| TEVA-CEPHALEXIN | 500MG | CAPSULE | Discontinued | 2020-10-08 | 2020-10-09 | 125979 |
| TEVA-CEPHALEXIN | 250MG | TABLET | Discontinued | 2020-10-08 | 2020-10-09 | 125982 |
| TEVA-CIPROFLOXACIN | 500MG | TABLET | Discontinued | 2017-06-27 | 2017-06-27 | 14049 |
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| TEVA-CLARITHROMYCIN | 250MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117529 |
| TEVA-CLARITHROMYCIN | 500MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117526 |
| TEVA-CLOBETASOL | 0.05% | LOTION | Discontinued | 2025-04-25 | 2025-04-25 | 255815 |
| TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64923 |
| TEVA-CLONAZEPAM | 0.5MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64926 |
| TEVA-CLONAZEPAM | 2MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 64929 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-25 | 2019-10-26 | 97248 |
| TEVA-DEFERASIROX | 500MG | TABLET FOR SUSPENSION | Discontinued | 2019-10-31 | 2019-11-01 | 97589 |
| TEVA-DEFERASIROX | 250MG | TABLET FOR SUSPENSION | Discontinued | 2020-01-21 | 2020-01-21 | 103796 |